Mentha cordifolia extract inhibits the development of hypertension in L-NAME-induced hypertensive rats

Journal of Medicinal Plants Research

Volumn 5, Issue 7, 2011, Pages 1175-1183

  Pakdeechote, Poungrat ^a   Kukongviriyapan, Upa ^a   Berkban, Warinee ^a   Prachaney, Parichat ^a   Kukongviriyapan, Veerapol ^a   Nakmareong, Saowanee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Antioxidants; Hypertension; L NAME; Mentha cordifolia Opiz.; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; GALLIC ACID; MALONALDEHYDE; MENTHA CORDIFOLIA EXTRACT; N(G) NITROARGININE METHYL ESTER; PLANT EXTRACT; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; HEART RATE; HEMODYNAMIC PARAMETERS; HINDLIMB; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MENTHA; MENTHA CORDIFOLIA; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR RESISTANCE;

MENTHA SPICATA; RATTUS;

EID: 79955565122     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Arnal JF, Warin L, Michel JB (1992). Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest., 90: 647-652.
2. Augustyniak RA, Victor RG, Morgan DA, Zhang W (2006). L-NAME-and ADMA-induced sympathetic neural activation in conscious rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 290: R726-732.
3. Bank N, Aynedjian HS, Khan GA (1994). Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension, 24: 322-328.
4. Baylis C, Mitruka B, Deng A (1992). Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest., 90: 278-281.
5. Bernatova I, Pechanova O, Kristek F (1999). Mechanism of structural remodelling of the rat aorta during long-term NG-nitro-L-arginine methyl ester treatment. Jpn. J. Pharmacol., 81: 99-106.
6. Biancardi VC, Bergamaschi CT, Lopes OU, Campos RR (2007). Sympathetic activation in rats with L-NAME-induced hypertension. Braz. J. Med. Biol. Res., 40: 401-408.
7. Bozin B, Mimica-Dukic N, Bogavac M, Suvajdzic L, Simin N, Samojlik I, Couladis M (2008). Chemical composition, antioxidant and antibacterial properties of Achillea collina Becker ex Heimerl s.l. and A. pannonica Scheele essential oils. Molecules, 13: 2058-2068.
8. Bryant CE, Allcock GH, Warner TD (1995). Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Br. J. Pharmacol., 114: 1673-1679.
9. Chen X, Touyz RM, Park JB, Schiffrin EL (2001). Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension, 38: 606-611.
10. Cunha RS, Cabral AM, Vasquez EC (1993). Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am. J. Hypertens., 6: 806-809.
11. Duarte J, Jimenez R, O'Valle F, Galisteo M, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuelo A, Tamargo J (2002). Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J. Hypertens, 20: 1843-1854.
12. Furchgott RF, Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nat., 288: 373-376.
13. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S (1990). Regional haemodynamic changes during oral ingestion of NGmonomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br. J. Pharmacol., 101: 10-12.
14. Gardiner SM, Dunn WR, Bennett T (1999). Chronic nitric oxide inhibition model six years on. Hypertension, 34: e4.
15. Gerova M, Masanova C, Pavlasek J (1995). Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat. Physiol. Res., 44: 131-134.
16. Gerova M, Torok J, Pechaoova O, Matuskova J (2004). Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production. Acta Pharmacol. Sin., 25: 1640-1646.
17. Gursoy N, Tepe B (2009). Determination of the antimicrobial and antioxidative properties and total phenolics of two "endemic" Lamiaceae species from Turkey: Ballota rotundifolia L. and Teucrium chamaedrys C. Koch. Plant Foods Hum Nutr., 64: 135-140.
18. Henrion D, Dowell FJ, Levy BI, Michel JB (1996). In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension, 28: 361-366.
19. Ka MH, Choi EH, Chun HS, Lee KG (2005). Antioxidative activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles, and sweet flag leaves. J. Agric. Food Chem., 53: 4124-4129.
20. Kojsova S, Jendekova L, Zicha J, Kunes J, Andriantsitohaina R, Pechanova O (2006). The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol. Res., 55(Suppl 1): S3-16.
21. Kristek F, Gerova M (1996). Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries. Physiol. Res., 45: 361-367.
22. Kung CF, Moreau P, Takase H, Luscher TF (1995). L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil. Hypertension, 26: 744-751.
23. Loeb AL, Longnecker DE (1992). Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am. J. Physiol., 262: H1494-1500.
24. Luangaram S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Pannangpetch P (2007). Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food Chem. Toxicol., 45: 448-455.
25. McKay DL, Blumberg JB (2006). A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res., 20: 619-633.
26. Moreno L, Bello R, Primo-Yufera E, Esplugues J (2002). Pharmacological properties of the methanol extract from Mentha suaveolens Ehrh. Phytother. Res., 16(Suppl 1): S10-13.
27. Morton JJ, Beattie EC, Speirs A, Gulliver F (1993). Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J. Hypertens., 11: 1083-1088.
28. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M (1991). Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. U. S. A., 88: 10045-10048.
29. Noll G, Tschudi M, Nava E, Luscher TF (1997). Endothelium and high blood pressure. Int. J. Microcirc. Clin. Exp., 17: 273-279.
30. Pechanova O, Bernatova I, Babal P, Martinez MC, Kysela S, Stvrtina S, Andriantsitohaina R (2004). Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens., 22: 1551-1559.
31. Pechanova O, Kashiba M, Inoue M (1999). Role of glutathione in stabilization of nitric oxide during hypertension developed by inhibition of nitric oxide synthase in the rat. Jpn J. Pharmacol., 81: 223-229.
32. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ (1993). Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension, 21: 660-666.
33. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992). Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension, 20: 298-303.
34. Runnie I, Salleh MN, Mohamed S, Head RJ, Abeywardena MY (2004). Vasorelaxation induced by common edible tropical plant extracts in isolated rat aorta and mesenteric vascular bed. J. Ethnopharmacol., 92: 311-316.
35. Sander M, Victor RG (1999). Neural mechanisms in nitric-oxide deficient hypertension. Curr. Opin. Nephrol. Hypertens., 8: 61-73.
36. Sompamit K, Kukongviriyapan U, Nakmareong S, Pannangpetch P, Kukongviriyapan V (2009). Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharideinduced endotoxaemia in mice. Eur. J. Pharmacol., 616: 192-199.
37. Sousa PJ, Linard CF, Azevedo-Batista D, Oliveira AC, Coelho-de-Souza AN, Leal-Cardoso JH (2009). Antinociceptive effects of the essential oil of Mentha x villosa leaf and its major constituent piperitenone oxide in mice. Braz. J. Med. Biol. Res., 42: 655-659.
38. Souza HC, Ballejo G, Salgado MC, Da Silva VJ, Salgado HC (2001). Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats. Am. J. Physiol. Heart Circ. Physiol., 280: H844-850.
39. Torok J (2008). Participation of nitric oxide in different models of experimental hypertension. Physiol. Res., 57: 813-825.
40. Varagic J, Jerkic M, Jovovic D, Nastic-Miric D, Adanja-Grujic G, Markovic-Lipkovski J, Lackovic V, Radujkovic-Kuburovic G, Kentera D (2000). Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am. J. Med. Sci., 320: 171-176.
41. Vaskonen T, Mervaala E, Krogerus L, Teravainen TL, Laakso J, Karppanen H, Vapaatalo H (1997). Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens. Res., 20: 183-192.
42. Vasquez EC, Cunha RS, Cabral AM (1994). Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis. Braz. J. Med. Biol. Res., 27: 767-774.
43. Villasenor IM, Echegoyen DE, Angelada JS (2002). A new antimutagen from Mentha cordifolia Opiz. Mutat. Res., 515: 141-146.
44. Villasenor IM, Sanchez AC (2009). Menthalactone, a new analgesic from Mentha cordifolia Opiz. Leaves. Z Naturforsch. C., 64: 809-812.
45. Zanchi A, Aubert JF, Brunner HR, Waeber B (1995). Vascular acetylcholine response during chronic NO synthase inhibition: In vivo versus in vitro. Cardiovasc. Res., 30: 122-129.
46. Zatz R, Baylis C (1998). Chronic nitric oxide inhibition model six years on. Hypertension, 32: 958-964.
47. Zheng W, Wang SY (2001). Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food Chem., 49: 5165-5170.
48. Zicha J, Dobesova Z, Kunes J (2006). Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertension. Res., 29: 1021-1027.